Search research articles
Contact Us
Filters
Showing results (61-70 of 93) with videos related to
Page
of 10
Sort By:
Blood Cancer Journal
|
August 7, 2024
Flow cytometric analysis of erythroid precursors and mutational signatures of lower risk myelodysplastic syndromes identify responders to erythroid stimulating agents
Marco G Raddi, Sara Bencini, Benedetta Peruzzi, et al.
British Journal of Haematology
|
August 26, 2024
Clinical and biological characteristics of patients presenting with carcinocythaemia: A retrospective, multicentre study by the French-speaking Cellular Hematology Group (GFHC)
Ludovic Suner, Elise Sourdeau, Thimali Ranaweera, et al.
British Journal of Haematology
|
May 4, 2026
High frequency of CD95<sup>+</sup>/CD45RA<sup>-</sup> regulatory T cells defines an immunosuppressive profile associated with MDS progression
Romain Vazquez, Nicolas Deredec, Ismael Boussaid, et al.
Ejhaem
|
December 18, 2025
Development of Machine-Assisted, Human-Centred Bone Marrow Cell Classification: Feasibility Analysis in Patients With Myelodysplastic Syndromes
Kiyoyuki Ogata, Yuto Mochimaru, Leonie Saft, et al.
Blood
|
July 30, 2010
The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation
Alexa S Green, Nicolas Chapuis, Thiago Trovati Maciel, et al.
Nature Communications
|
December 22, 2018
A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset
Dorothée Selimoglu-Buet, Julie Rivière, Hussein Ghamlouch, et al.
Blood
|
November 19, 2016
Architectural and functional heterogeneity of hematopoietic stem/progenitor cells in non-del(5q) myelodysplastic syndromes
Virginie Chesnais, Marie-Laure Arcangeli, Caroline Delette, et al.
Haematologica
|
September 22, 2011
High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study
François Vergez, Alexa S Green, Jerome Tamburini, et al.
Blood Cancer Journal
|
March 20, 2021
Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis
Romain Vazquez, Claire Breal, Loria Zalmai, et al.
Elife
|
April 30, 2021
<i>ImmunoCluster</i> provides a computational framework for the nonspecialist to profile high-dimensional cytometry data
James W Opzoomer, Jessica A Timms, Kevin Blighe, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 93) with videos related to
Sort By:
Page
of 10
Blood Cancer Journal
|
August 7, 2024
Flow cytometric analysis of erythroid precursors and mutational signatures of lower risk myelodysplastic syndromes identify responders to erythroid stimulating agents
Marco G Raddi, Sara Bencini, Benedetta Peruzzi, et al.
British Journal of Haematology
|
August 26, 2024
Clinical and biological characteristics of patients presenting with carcinocythaemia: A retrospective, multicentre study by the French-speaking Cellular Hematology Group (GFHC)
Ludovic Suner, Elise Sourdeau, Thimali Ranaweera, et al.
British Journal of Haematology
|
May 4, 2026
High frequency of CD95<sup>+</sup>/CD45RA<sup>-</sup> regulatory T cells defines an immunosuppressive profile associated with MDS progression
Romain Vazquez, Nicolas Deredec, Ismael Boussaid, et al.
Ejhaem
|
December 18, 2025
Development of Machine-Assisted, Human-Centred Bone Marrow Cell Classification: Feasibility Analysis in Patients With Myelodysplastic Syndromes
Kiyoyuki Ogata, Yuto Mochimaru, Leonie Saft, et al.
Blood
|
July 30, 2010
The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation
Alexa S Green, Nicolas Chapuis, Thiago Trovati Maciel, et al.
Nature Communications
|
December 22, 2018
A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset
Dorothée Selimoglu-Buet, Julie Rivière, Hussein Ghamlouch, et al.
Blood
|
November 19, 2016
Architectural and functional heterogeneity of hematopoietic stem/progenitor cells in non-del(5q) myelodysplastic syndromes
Virginie Chesnais, Marie-Laure Arcangeli, Caroline Delette, et al.
Haematologica
|
September 22, 2011
High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study
François Vergez, Alexa S Green, Jerome Tamburini, et al.
Blood Cancer Journal
|
March 20, 2021
Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis
Romain Vazquez, Claire Breal, Loria Zalmai, et al.
Elife
|
April 30, 2021
<i>ImmunoCluster</i> provides a computational framework for the nonspecialist to profile high-dimensional cytometry data
James W Opzoomer, Jessica A Timms, Kevin Blighe, et al.
Page
of 10